JPH0816055B2 - Oral patch - Google Patents
Oral patchInfo
- Publication number
- JPH0816055B2 JPH0816055B2 JP62207585A JP20758587A JPH0816055B2 JP H0816055 B2 JPH0816055 B2 JP H0816055B2 JP 62207585 A JP62207585 A JP 62207585A JP 20758587 A JP20758587 A JP 20758587A JP H0816055 B2 JPH0816055 B2 JP H0816055B2
- Authority
- JP
- Japan
- Prior art keywords
- carrier
- patch
- bacterial cellulose
- thickness
- cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920002749 Bacterial cellulose Polymers 0.000 claims description 14
- 239000005016 bacterial cellulose Substances 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 11
- 239000011505 plaster Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 5
- 210000000214 mouth Anatomy 0.000 claims description 2
- 238000000855 fermentation Methods 0.000 claims 1
- 230000004151 fermentation Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 210000004400 mucous membrane Anatomy 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000004898 kneading Methods 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 208000003265 stomatitis Diseases 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000007565 gingivitis Diseases 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 210000002200 mouth mucosa Anatomy 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 description 2
- 244000283763 Acetobacter aceti Species 0.000 description 2
- 235000007847 Acetobacter aceti Nutrition 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 229940106164 cephalexin Drugs 0.000 description 2
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- KPHWPUGNDIVLNH-UHFFFAOYSA-M diclofenac sodium Chemical compound [Na+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl KPHWPUGNDIVLNH-UHFFFAOYSA-M 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- -1 etc. Chemical compound 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 210000004195 gingiva Anatomy 0.000 description 2
- 235000021312 gluten Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 210000001724 microfibril Anatomy 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229940063674 voltaren Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- KGDYJBQNHKNUDO-UHFFFAOYSA-N 1,4-diphenylpyrrolidine-2,3-dione Chemical compound C1(=CC=CC=C1)C1C(C(N(C1)C1=CC=CC=C1)=O)=O KGDYJBQNHKNUDO-UHFFFAOYSA-N 0.000 description 1
- NJPQAIBZIHNJDO-UHFFFAOYSA-N 1-dodecylpyrrolidin-2-one Chemical compound CCCCCCCCCCCCN1CCCC1=O NJPQAIBZIHNJDO-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 1
- 241000589220 Acetobacter Species 0.000 description 1
- 244000235858 Acetobacter xylinum Species 0.000 description 1
- 235000002837 Acetobacter xylinum Nutrition 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920001340 Microbial cellulose Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- XMEVHPAGJVLHIG-FMZCEJRJSA-N chembl454950 Chemical compound [Cl-].C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H]([NH+](C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O XMEVHPAGJVLHIG-FMZCEJRJSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229940045574 dibucaine hydrochloride Drugs 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- QYIXCDOBOSTCEI-FBVYSKEZSA-N epidihydrocholesterin Chemical compound C([C@@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-FBVYSKEZSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229960002660 mepivacaine hydrochloride Drugs 0.000 description 1
- RETIMRUQNCDCQB-UHFFFAOYSA-N mepivacaine hydrochloride Chemical compound Cl.CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C RETIMRUQNCDCQB-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229960004368 oxytetracycline hydrochloride Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229960001309 procaine hydrochloride Drugs 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002494 tetracaine hydrochloride Drugs 0.000 description 1
- 229960004989 tetracycline hydrochloride Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 229940072358 xylocaine Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Description
【発明の詳細な説明】 <産業上の利用分野> 本発明は口内炎、歯肉炎、歯牙矯正治療などに使用さ
れる口腔内貼付剤に関する。DETAILED DESCRIPTION OF THE INVENTION <Industrial field of application> The present invention relates to an oral patch for use in stomatitis, gingivitis, orthodontic treatment and the like.
<従来の技術> 近年、生体内に薬物を投与して各種疾患の治療や予防
を行なうための製剤として薬物の経皮吸収を利用した局
所からの経皮投与製剤が活発に開発されている。その中
にあって、口内炎、歯肉炎などの治療、あるいは歯牙の
矯正などを目的とした口腔粘膜用の貼付剤の開発も開発
されているが、その製剤化の際に用いられる担持体とし
ては従来より、プラスチック、紙、不織布、織布、金属
箔あるいはこれらの組合わせによる積層フィルムが用い
られて来た。<Prior Art> In recent years, a topical transdermal preparation utilizing transdermal absorption of a drug has been actively developed as a preparation for treating or preventing various diseases by administering a drug into a living body. Among them, development of a patch for oral mucosa for the treatment of stomatitis, gingivitis, etc., or for the correction of teeth, etc. has been developed, but as a carrier used in the formulation thereof, Conventionally, a laminated film made of plastic, paper, non-woven fabric, woven fabric, metal foil, or a combination thereof has been used.
<発明が解決しようとする問題点> しかし、これらの担持体にはいくつかの問題点があ
る。口腔内貼付剤の担持体として以下の条件を満足させ
ることが望ましい。先ず、口腔内で使用するため、誤っ
て飲み込んだ場合にも安全性に心配がないように可食性
であることが望ましい。また、唾液によって濡れるた
め、濡れた状況下での強度、耐摩耗性が必要である。更
に粘膜に用いられるため、使用時、刺激、異和感がな
く、弾力性に富み、柔軟である必要がある。このために
は担持体自身がある程度水分を吸収する性質が求められ
る。これらの要求性能からみた場合、従来より使用され
ているプラスチック、金属箔は可食性でなく、水分吸収
性が無く、硬く、使用時ごわごわした異和感がある。紙
は可食性であるものの、濡れに対して弱い欠点を有す
る。不織布や布はこれらの問題点にかなりの解決を与え
ているものの、可食性ではなく、水分吸収性が弱いた
め、使用時の異和感が否めない。<Problems to be Solved by the Invention> However, these carriers have some problems. It is desirable that the carrier for the oral patch satisfy the following conditions. First, since it is used in the oral cavity, it is desirable that it be edible so that there is no concern about safety even if it is accidentally swallowed. Further, since it is wet with saliva, strength and abrasion resistance under wet conditions are required. Furthermore, since it is used for mucous membranes, it is required to be flexible and flexible without any irritation or discomfort during use. For this purpose, the carrier itself is required to have a property of absorbing water to some extent. From the viewpoint of these required performances, conventionally used plastics and metal foils are not edible, have no water absorption, are hard, and have a rough feeling when used. Although paper is edible, it has the drawback of being weak against wetting. Although non-woven fabrics and cloths provide a considerable solution to these problems, they are not edible and have poor moisture absorption, which makes them uncomfortable when used.
<問題点を解決するための手段> そこで発明者らはこれらの諸問題点を解決した新しい
担持体について種々検討を進めて来た結果、ある種の微
生物によって産生されるセルロースを主成分として含む
多糖類(以下、バクテリアセルロースと呼ぶ)を用いて
作成されたシート状フィルムが、従来の問題点を解決し
た優れた口腔内貼付剤の担持体になるうることを確認
し、本発明を完成するに至った。まず、本発明でいう、
バクテリアセルロースは以下のようにして得ることがで
きる。<Means for Solving Problems> The inventors of the present invention have made various studies on new carriers that solve these problems, and as a result, contain cellulose produced by a certain kind of microorganism as a main component. It was confirmed that a sheet-like film made of a polysaccharide (hereinafter referred to as bacterial cellulose) can be an excellent carrier for an oral patch that solves the conventional problems, and completes the present invention. Came to. First, in the present invention,
Bacterial cellulose can be obtained as follows.
バクテリアセルロースを生産する微生物は、アセトバ
クター属,シュードモナス属,アグロバクテリウム属な
どに属し、一例を挙げればアセトバクター・アセチ・サ
ブスピーシス・キシリナム(Acetobacter aceti subsp.
xylinum)ATCC.10821を挙げることができる。Microorganisms that produce bacterial cellulose belong to the genus Acetobacter, the genus Pseudomonas, the genus Agrobacterium, and the like. As an example, Acetobacter aceti subsp. Xylinum (Acetobacter aceti subsp.
xylinum) ATCC.10821.
バクテリアセルロースを生産させる為には炭素源,窒
素源,無機塩類,その他必要に応じてアミノ酸,ビタミ
ン等の有機微量栄養素を含有する通常の栄養培地に微生
物を接種し静置又はゆるやかに通気撹拌を行なう。炭素
源としてはグルコース,シュークロース,マルトース,
澱粉水解物、糖蜜等が使用され、その他エタノール,
酸,クエン酸等も単独或は上記他の炭素源と併用して用
いられる。窒素源としては硫酸アンモニウム,塩化アン
モニウム,リン酸アンモニウム等のアンモニウム塩,硝
酸塩,尿素,ペプトン等有機或は無機の窒素源が使用さ
れる。有機微量栄養素としてはアミノ酸,ビタミン,脂
肪族,核酸,更にこれらのものを含有するペプトン,カ
ザミノ酸,酵母エキス,大豆蛋白分解物等が使用され、
生育にアミノ酸等を要求する栄養要求性変異株を使用す
る場合には要求される栄養素を補添することが必要であ
る。無機塩類としてはリン酸塩,マグネシウム塩,カル
シウム塩,鉄塩,マンガン塩等が使用される。In order to produce bacterial cellulose, microorganisms are inoculated into a normal nutrient medium containing carbon sources, nitrogen sources, inorganic salts, and if necessary, organic micronutrients such as amino acids and vitamins, and the mixture is allowed to stand or gently aerated. To do. Carbon sources include glucose, sucrose, maltose,
Hydrolyzed starch, molasses, etc. are used, other ethanol,
Acids, citric acid, etc. may be used alone or in combination with the above-mentioned other carbon sources. As the nitrogen source, ammonium salts such as ammonium sulfate, ammonium chloride and ammonium phosphate, nitrates, urea, organic or inorganic nitrogen sources such as peptone are used. As organic micronutrients, amino acids, vitamins, aliphatics, nucleic acids, and peptone, casamino acid, yeast extract, soybean protein hydrolyzate containing these substances are used.
When using an auxotrophic mutant that requires amino acids or the like for growth, it is necessary to supplement the required nutrients. Phosphates, magnesium salts, calcium salts, iron salts, manganese salts and the like are used as the inorganic salts.
培養は通常の培養条件下で行えば良く、pHを5ないし
9、温度を20ないし40℃に制御しつつ1〜7日間所定の
厚さになるまで培養することにより培養液の表層に微生
物セルロースが生産される。Cultivation may be carried out under ordinary culture conditions. The pH of the culture solution is controlled to 5 to 9 and the temperature is controlled to 20 to 40 ° C for 1 to 7 days until a predetermined thickness is reached, whereby microbial cellulose is added to the surface layer of the culture solution. Is produced.
得られたバクテリアセルロースは幅100〜500Å、厚さ
10〜200Å程度のリボン状ミクロフィブリルがからみ合
った構造をしており、95%以上の多量の水を含んだゲル
状態をしている。The obtained bacterial cellulose has a width of 100-500Å and a thickness of
It has a structure in which ribbon-shaped microfibrils of about 10 to 200Å are entangled with each other, and it is in a gel state containing a large amount of water of 95% or more.
これからシート状フィルムを得るには、所定の厚さの
ゲル状バクテリアセルロースを充分に洗浄した後、プレ
ス機にてプレス脱水し、加熱乾燥することによって得ら
れる。場合によってはこのゲル状バクテリアセルロース
を離解して、そのまゝ、またはその他の方法で得られる
セルロースなどの繊維状物質を50%以下混合して抄紙す
ることによってシート状フィルムに加工することも可能
である。バクテリアセルロースの比率が小さくなると強
度が低下し担持体としての性能が低下する。フィルムの
厚さは1ないし1,000μmで用いられるが好ましい厚さ
は5ないし500μmである。To obtain a sheet-like film from this, gel-like bacterial cellulose having a predetermined thickness is thoroughly washed, then dehydrated by pressing with a pressing machine and dried by heating. Depending on the case, it is also possible to disintegrate this gel-like bacterial cellulose and mix it with 50% or less of fibrous substances such as cellulose obtained by that method or other methods to make paper and process it into a sheet-like film. Is. When the ratio of bacterial cellulose is small, the strength is low and the performance as a carrier is low. The thickness of the film used is 1 to 1,000 μm, but the preferred thickness is 5 to 500 μm.
かくして得られたシート状フィルムは従来の担持体に
比較して優れた性質を有する。即ち、バクテリアセルロ
ースは食品に供せられており可食性であること、通常の
セルロースに比し、極めて細いミクロフィブリルが密に
からみあった構造を有しているため、濡れた状態でも強
い強度と耐摩耗性を保っている。また、水を吸収する能
力に優れ、唾液を吸収した時膨潤し、柔軟性に富むた
め、口腔内粘膜を傷めず貼付時の異和感も少ない。本発
明によって得られた担持体を用いて口腔用貼付剤を調製
するには一般に採用されている貼付剤の製造方法が採用
できる。例えれば、該担持体に経皮吸収性薬剤を含有す
る膏体組成物を塗布し、乾燥した後、感圧性接着剤を塗
布する方法、または、膏体組成物と感圧性接着剤をあら
かじめ混合した組成物を塗布、乾燥する方法、あるいは
これらの膏体組成物および接着剤をあらかじめ剥離シー
トに塗布乾燥した後、該担持体に転着して作ることも可
能である。The sheet-like film thus obtained has excellent properties as compared with the conventional carrier. That is, bacterial cellulose is edible because it has been provided to food, and has a structure in which extremely fine microfibrils are tightly entangled with each other, as compared with ordinary cellulose, and therefore strong strength and resistance even in a wet state. Maintains wear resistance. In addition, it has an excellent ability to absorb water, swells when saliva is absorbed, and is highly flexible, so that it does not damage the oral mucosa and gives little discomfort when applied. In order to prepare an oral patch using the carrier obtained by the present invention, a generally-used patch manufacturing method can be adopted. For example, a method of applying a plaster composition containing a percutaneously absorbable drug to the carrier, drying it, and then applying a pressure-sensitive adhesive, or mixing the plaster composition and the pressure-sensitive adhesive in advance. It is also possible to apply and dry the composition described above, or to apply the plaster composition and the adhesive to a release sheet in advance and then dry and then transfer the composition to the carrier.
本発明に供せられる経皮吸収性薬剤としては以下のも
のが例示できる。Examples of the transdermal drug that can be used in the present invention include the following.
口内炎,歯痛に対してインドメタシン,ボルタレン,
ジフェニルジオキソピラリジン,エピジヒドロコレステ
リン,アスピリン,キシロカインなど、歯肉炎に対して
セファレキシン,塩酸テトラサイクリン,塩酸オキシテ
トラサイクリン,フラジオマイシン,α−アミラーゼ,
クロラムフェニコールなど、局部麻酔用として塩酸プロ
カイン,塩酸テトラカイン,塩酸ジブカイン,塩酸メピ
バカインなど、歯牙矯正用としてプロスタグランジンF2
α,ビタミンD誘導体などが挙げられる。更に、心臓
病,神経精神系病,呼吸器系病などの薬剤も適用され
る。Stomatitis, toothache, indomethacin, voltaren,
Cephalexin, tetracycline hydrochloride, oxytetracycline hydrochloride, fradiomycin, α-amylase, etc. for gingivitis such as diphenyldioxopyrrolidine, epidihydrocholesterin, aspirin, xylocaine
Chloramphenicol, etc. for local anesthesia, procaine hydrochloride, tetracaine hydrochloride, dibucaine hydrochloride, mepivacaine hydrochloride, etc., prostaglandin F 2 for orthodontics
Examples include α and vitamin D derivatives. Furthermore, drugs for heart disease, neuropsychiatric disease, respiratory disease, etc. are also applied.
これらの薬剤は単独で膏体層として塗布することも可
能ではあるが、一般には賦形剤,溶解助剤などの補助剤
を用い薬剤とし混練し調製された組成物を膏体層として
使用する。補助剤を例示するならば、オリーブ油,イソ
プロピルミリステート,流動パラフィン,精製水,ポリ
エチレングリコールなどの溶解補助剤,グリセリン,ソ
ルビトール,ピロリドンカルボン酸塩などの保湿剤,カ
ルボキシメチルセルロースなどの増粘剤,亜鉛華,グル
テン,寒天などの賦形剤,炭酸ナトリウムなどのpH調整
剤、更にはコール酸塩,サポニン,多価アルコールエス
テル,N−アシルアミノ酸塩などの界面活性剤及びドデシ
ルピロリドンなどを代表とする経皮吸収促進剤などが挙
げられる。これらの配合比は薬剤の種類、効果によって
きめられる。Although it is possible to apply these agents alone as a plaster layer, generally, a composition prepared by kneading as an agent with an auxiliary agent such as an excipient and a dissolution aid is used as the plaster layer. . Examples of adjuvants include olive oil, isopropyl myristate, liquid paraffin, purified water, solubilizers such as polyethylene glycol, humectants such as glycerin, sorbitol, and pyrrolidone carboxylate, thickeners such as carboxymethylcellulose, zinc. Representative examples include excipients such as flower, gluten, and agar, pH adjusting agents such as sodium carbonate, surfactants such as cholate, saponin, polyhydric alcohol ester, N-acyl amino acid salt, and dodecylpyrrolidone. Examples include transdermal absorption enhancers. The blending ratio of these is determined by the type and effect of the drug.
感圧性接着剤は、薬剤の放出性、水分存在下での粘膜
との接着剤、安全性などを考慮した上で採用されるが、
一般的にはポリアクリル酸系物質,ポリ酢酸ビニール,
部分加水分解物などのビニール系高分子物質,ゴム系物
質,メチルセルロースなどのセルロース誘導体,寒天な
どの多糖類,ゼラチンなどの蛋白質,ポリアミノ酸など
が用いられる。The pressure-sensitive adhesive is adopted after considering the release of the drug, the adhesive with the mucous membrane in the presence of water, safety, etc.
Generally, polyacrylic acid type substances, polyvinyl acetate,
Vinyl-based polymeric substances such as partial hydrolysates, rubber-based substances, cellulose derivatives such as methylcellulose, polysaccharides such as agar, proteins such as gelatin, and polyamino acids are used.
<発明の効果> かくして得られた口腔内貼付剤は、粘膜との密着性が
良く、唾液によって担持体が適度に水分を吸収、膨潤す
ることにより、貼付剤全体が柔わらかくなり、従来のも
のに比較して歯と粘膜との間などでクッション効果を持
ち、粘膜を傷めず、使用時も密着性にすぐれ異和感もほ
とんど認められなかった。また、濡れた状態でも強い強
度と耐摩耗性を保持し、やぶれることは全くなかった。<Effects of the Invention> The thus obtained oral patch has good adhesion to the mucous membrane, and the carrier absorbs and swells water appropriately by saliva, so that the entire patch becomes soft and It had a cushioning effect between the teeth and the mucous membranes, did not damage the mucous membranes, had excellent adhesiveness during use, and almost no discomfort was observed. Further, even when it was wet, it retained strong strength and abrasion resistance and did not shake at all.
<実施例> 以下に本発明の実施例を示し、更に具体的に説明す
る。<Examples> Examples of the present invention will be shown below, and will be described more specifically.
実施例1 バクテリアセルロース担持体の調整例 シュクロース5g/dl,酵母エキス0.5g/dl,硫安0.5g/dl,
リン酸水素カリウム(KH2PO4)0.3g/dl,硫酸マグネシウ
ム(MgSO47H2O)0.05g/dlからなる組成の培地(pH5.0)
50mlをシャーレに張り込み、120℃で20分間蒸気殺菌し
て培養液を作成した。Example 1 Preparation example of bacterial cellulose carrier Sucrose 5 g / dl, yeast extract 0.5 g / dl, ammonium sulfate 0.5 g / dl,
Potassium hydrogen phosphate (KH 2 PO 4) 0.3g / dl, magnesium sulfate (MgSO 4 7H 2 O) medium composition consisting of 0.05g / dl (pH5.0)
50 ml was put in a petri dish and steam sterilized at 120 ° C. for 20 minutes to prepare a culture solution.
次いで、この培養液に、酵母エキス0.5g/dl,ペプトン
0.3g/dl,マンニトール2.5g/dlからなる組成の試験管斜
面寒天培地(pH6.0)で30℃,3日間生育させたアセトバ
クター・アセチ・サブスピーシス・キシリナム(ATCC 1
0821)を1白金耳ずつ接種し、30℃で培養した。4日間
培養することにより、培養液の上層に白色ゲル状の厚さ
約3mmのバクテリアセルロースの膜を形成した。この膜
を2%水酸化ナトリウム水溶液で洗浄した後、水にて充
分に洗浄した後、次いで、布ないし約200メッシュの金
網にはさみプレス機にてプレス(20〜30kg/cm2)し、脱
水した。しかる後、150℃,5kg/cm2,5分間の条件でプレ
スすることにより、厚さ約30μmの乾燥シート状フィル
ムが得られた。このフィルムの強度は以下の通りであっ
た。Then, to this culture solution, yeast extract 0.5 g / dl, peptone
Acetobacter aceti subspice xylinum (ATCC 1) grown in a test tube slant agar (pH 6.0) composed of 0.3 g / dl and mannitol 2.5 g / dl for 3 days at 30 ℃
0821) was inoculated in 1 platinum loop each and cultured at 30 ° C. By culturing for 4 days, a white gel-like bacterial cellulose film having a thickness of about 3 mm was formed on the upper layer of the culture solution. After washing this membrane with a 2% aqueous sodium hydroxide solution, thoroughly washing it with water, and then pressing it (20-30 kg / cm 2 ) with a cloth press or a wire mesh of about 200 mesh with a scissor press to dehydrate it. did. Then, by pressing at 150 ° C. for 5 minutes at 5 kg / cm 2 , a dry sheet-like film having a thickness of about 30 μm was obtained. The strength of this film was as follows.
引張り強度 22kg/mm2(21kg/mm2) 引張り弾性率 1600kg/mm2(400kg/mm2) ( )内:対照品ポリエステルフィルム 実施例2 混抄フィルムの調製例 実施例1の培養条件で200mlの三角フラスコ中にて30
日間培養することにより厚さ1cm以上のゲル状のバクテ
リアセルロースが得られた。これを120℃,20分にて加熱
殺菌した後、2%水酸化ナトリウム液及び水にて洗浄し
精製した。次いでこの精製ゲルを約4倍量の水を用い離
解機にて撹拌速度3000rpm,30分間離解した。この離解物
に対し40重量%のコットンリンターパルプ離解液を加
え、角型抄紙機を用い厚さ約100μmの担持体を得た。Tensile strength 22 kg / mm 2 (21 kg / mm 2 ) Tensile modulus 1600 kg / mm 2 (400 kg / mm 2 ) (): Reference product Polyester film Example 2 Preparation example of blended film 200 ml under the culture conditions of Example 1 30 in Erlenmeyer flask
By culturing for a day, gel-like bacterial cellulose with a thickness of 1 cm or more was obtained. This was sterilized by heating at 120 ° C. for 20 minutes and then washed with a 2% sodium hydroxide solution and water for purification. Next, this purified gel was disintegrated with about 4 times the amount of water using a disintegrator at a stirring speed of 3000 rpm for 30 minutes. 40% by weight of cotton linter pulp disintegration liquid was added to this disintegrated material to obtain a carrier having a thickness of about 100 μm using a rectangular paper machine.
実施例3 口内炎用貼付剤 (膏体組成物) 重量部 ボルタレン 1 インドメタシン 1 寒 天 10 ポリビニルアルコール 10 ポリエチレングリコール(#400) 15 グリセリン 5 精 製 水 50 コール酸ナトリウム 1 (感圧性接着剤) 重量部 ポリアクリル酸ナトリウム(▲▼=18,000) 40 ポリアクリルアミド 40 精 製 水 40 膏体各成分を混練して得られた該組成物を、実施例1
で調製された担持体上に約100μmの厚さに展延し、自
然乾燥した。しかる後、あらかじめ混練して得た感圧性
接着剤組成物を、約5μmの厚さに展延し自然乾燥し
た。Example 3 Patch for stomatitis (paste composition) parts by weight Voltaren 1 indomethacin 1 agar 10 polyvinyl alcohol 10 polyethylene glycol (# 400) 15 glycerin 5 purified water 50 sodium cholate 1 (pressure-sensitive adhesive) parts by weight Sodium polyacrylate (▲ ▼ = 18,000) 40 Polyacrylamide 40 Purified water 40 plaster The composition obtained by kneading each component was used in Example 1
It was spread to a thickness of about 100 μm on the carrier prepared in (1) and naturally dried. Thereafter, the pressure-sensitive adhesive composition obtained by kneading in advance was spread to a thickness of about 5 μm and naturally dried.
かくして得られた口内炎用貼付剤は薬剤面を患部に貼
付した時担持体が適度に水分を吸収し、柔軟性に富み、
患部の動きによく追随し異和感を感じなかった。又、や
ぶれることも全くなかった。The thus obtained patch for stomatitis absorbs water moderately when the drug surface is applied to the affected part, and is rich in flexibility,
He followed the movement of the affected area well and felt no discomfort. Moreover, there was no shake at all.
実施例4 歯牙矯正用貼付剤 (膏体組成物) 重量部 プロスタグランジンF2α 0.1 ポリ酢酸ビニール 20 寒 天 7 ポリビニルアルコール 7 ポリビニルピロリドン 2 精 製 水 200 カラヤガム 23 CMCナトリウム 7 グルテン 10 ポリエチレングリコール(#400) 13 ソルビトール(70%水溶液) 7 炭酸ナトリウム 5 混練して得た上記膏体組成物を実施例1で調製された
担持体に約500μmの厚さに塗布し、40℃にて乾燥し
た。得られた口腔内貼付剤を歯肉に薬剤面を貼付した結
果、従来の貼付剤に比し、歯肉との密着感がよく、柔軟
性にとみ、口腔粘膜との間で、クッション効果をもち、
粘膜をいためることもなかった。Example 4 Orthodontic patch (paste composition) parts by weight prostaglandin F 2 α 0.1 polyvinyl acetate 20 agar 7 polyvinyl alcohol 7 polyvinylpyrrolidone 2 purified water 200 karaya gum 23 CMC sodium 7 gluten 10 polyethylene glycol ( # 400) 13 sorbitol (70% aqueous solution) 7 sodium carbonate 5 The above paste composition obtained by kneading was applied to the carrier prepared in Example 1 to a thickness of about 500 μm, and dried at 40 ° C. . As a result of sticking the drug surface to the gingiva of the obtained oral patch, as compared with the conventional patch, the feeling of close contact with the gingiva is good, the flexibility is good, and the cushioning effect between the oral mucosa is provided,
He did not heal the mucous membranes.
実施例5 歯肉炎用貼付剤 (膏体組成物) 重量部 セファレキシン 16 セルロースアセテートフタレート 20 ヒドロキシプロピルセルロース 50 カルボキシメチルセルロース 30 グリセリン 60 ゼラチン 40 精 製 水 100 混練して得た上記膏体組成物を、実施例2で調製され
た厚さ約100μmの担持体に約500μmの厚さに塗布し40
℃にて乾燥して目的とする口腔内貼付剤を得た。このも
のの薬剤面を患部に貼付した結果、担持体は適度に水分
を吸収し、柔軟性にとみ、使用感も良好であった。又、
装着時ほぐれることもなく充分の耐久性を保った。Example 5 Patch for Gingivitis (Plastic Composition) Parts by Weight Cephalexin 16 Cellulose Acetate Phthalate 20 Hydroxypropyl Cellulose 50 Carboxymethyl Cellulose 30 Glycerin 60 Gelatin 40 Purified Water 100 The above plaster composition obtained by kneading was carried out. The carrier prepared in Example 2 and having a thickness of about 100 μm was coated to a thickness of about 500 μm.
After drying at ℃, the intended oral patch was obtained. As a result of sticking the drug surface of this product to the affected area, the carrier absorbs water moderately, is flexible, and has a good feeling in use. or,
Maintained sufficient durability without loosening when attached.
Claims (1)
らなる製剤において、担持体として発酵法により得られ
るゲル状態のバクテリアセルロースを主成分とし、これ
を脱水・乾燥せしめたシート状フィルムのバクテリアセ
ルロースを用いることを特徴とする口腔内貼付剤。1. A sheet comprising a carrier and a plaster layer containing a percutaneously absorbable drug, the main component of which is bacterial cellulose in a gel state obtained by a fermentation method as a carrier, which is dehydrated and dried. A patch for oral cavity, characterized by using bacterial cellulose in the form of a film.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62207585A JPH0816055B2 (en) | 1987-08-21 | 1987-08-21 | Oral patch |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62207585A JPH0816055B2 (en) | 1987-08-21 | 1987-08-21 | Oral patch |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6450815A JPS6450815A (en) | 1989-02-27 |
| JPH0816055B2 true JPH0816055B2 (en) | 1996-02-21 |
Family
ID=16542199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62207585A Expired - Lifetime JPH0816055B2 (en) | 1987-08-21 | 1987-08-21 | Oral patch |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0816055B2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001045678A2 (en) * | 1999-12-21 | 2001-06-28 | Id Pharma Gmbh | Medicament, a method for its production and the use thereof |
| CN101879148B (en) * | 2010-06-25 | 2012-07-18 | 东华大学 | Method for preparing bacterial cellulose hydrogel temperature-reducing plaster and product thereof |
| WO2013094077A1 (en) * | 2011-12-19 | 2013-06-27 | L'oreal | Cosmetic bio-cellulose sheet for lips |
| TWI771563B (en) * | 2019-02-01 | 2022-07-21 | 嬌朋生技股份有限公司 | Biological fiber composition |
| CN114099478A (en) * | 2021-12-02 | 2022-03-01 | 中国科学技术大学 | Oral wound protective film and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58174307A (en) * | 1982-04-06 | 1983-10-13 | Teikoku Seiyaku Kk | Edible drug for attaching to oral cavity |
| JPS61132149A (en) * | 1984-11-30 | 1986-06-19 | Nakano Vinegar Co Ltd | Food effective to lower cholesterol level |
| JPS61215635A (en) * | 1985-03-22 | 1986-09-25 | Agency Of Ind Science & Technol | Cellulosic microcrystal |
| JPS6283854A (en) * | 1985-10-07 | 1987-04-17 | Ajinomoto Co Inc | Aqueous food |
-
1987
- 1987-08-21 JP JP62207585A patent/JPH0816055B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6450815A (en) | 1989-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4594240A (en) | Sheet-shape adhesive preparation | |
| RU2332238C2 (en) | Composition for pads, wound dressing and other articles contacting skin | |
| RU2393877C2 (en) | Adhesive composition | |
| US6455067B1 (en) | Transdermal patch for nonsteroidal antiinflammatory drug(s) | |
| US6410048B1 (en) | Prolamin-plant polar lipid combination, preparation method and applications | |
| CA2253980A1 (en) | Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof | |
| CN101386877A (en) | A kind of preparation method of bacterial cellulose composite film and its application as mask material | |
| TR200101049T2 (en) | Cyclic tetrapeptide compound and its use | |
| JP4624108B2 (en) | Skin external material and anti-tarnish agent and wrinkle remover using the same | |
| JPH10508018A (en) | Denture stabilizing composition | |
| TW201142033A (en) | Bacterial cellulose film, and use thereof | |
| CN115353647B (en) | A self-repairing marine collagen peptide-based composite hydrogel and its preparation method | |
| US5877233A (en) | Denture adhesive compositions | |
| CN113069437A (en) | External gel emplastrum containing loxoprofen and medicinal salt thereof and preparation method thereof | |
| AU4298597A (en) | Oral composition | |
| JPH0816055B2 (en) | Oral patch | |
| CN109966540B (en) | Preparation method and application of nano chitin composite calcium alginate medical dressing | |
| JPH057369B2 (en) | ||
| JPS5993012A (en) | Base for pack | |
| US9320721B2 (en) | Mucoadhesive patch with opposite ratios of nonionic and anionic hydrocolloids in adhesive and backing layer | |
| FR2657015A1 (en) | MATERIAL HAVING BIOLOGICAL ACTIVITY, PROCESS FOR MANUFACTURING AND DRESSING. | |
| JPH10316590A (en) | Topical narcotic for external use | |
| PT97174A (en) | Process for the preparation of an adhesive composition comprising a polymeric organic adhesive and a polymer substituted with amine | |
| CA2395209A1 (en) | Pack agent in a sheet form | |
| KR20240103113A (en) | Hydrogel patch incorporating liposomes and transdermal delivery system (tds) |